MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $298,000 | -34.1% | 47,980 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $452,000 | -9.6% | 47,980 | +30.2% | 0.00% | -20.0% |
| Q2 2021 | $500,000 | -16.1% | 36,839 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $596,000 | -39.2% | 36,839 | 0.0% | 0.01% | -40.0% |
| Q4 2020 | $980,000 | +42.9% | 36,839 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $686,000 | -2.0% | 36,839 | +23.2% | 0.01% | 0.0% |
| Q2 2020 | $700,000 | – | 29,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |